BEIJING, Dec. 23, 2011 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) (“Nuokang” or the “Company”), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hospital-based medical products, today announced that the Company held its annual general meeting at 9 a.m. Beijing time on December 23, 2011. Each of the proposals submitted for shareholder approval was approved.
